α,α-disubstituted β-amino amides eliminate

Dominik Ausbacher, Lindsey A Miller, Darla M Goeres, Philip S Stewart, Morten B Strøm, Adyary Fallarero

Open access · goldAbstract read

In one paragraph

Article in Biofilm, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.4field-weighted citation impact, top 40% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

The anti-infective potential of human milk oligosaccharides in carbohydrate powder in implant-associated infection with Staphylococcus aureus.PloS one · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Dominik AusbacherNatural Products and Medicinal Chemistry Research Group, Department of Pharmacy, UiT The Arctic University of Norway, N-9037, Tromsø, Norway.

Lindsey A MillerCenter for Biofilm Engineering, Montana State University, Bozeman, MT, 59717, USA.

Darla M GoeresCenter for Biofilm Engineering, Montana State University, Bozeman, MT, 59717, USA.

Philip S StewartCenter for Biofilm Engineering, Montana State University, Bozeman, MT, 59717, USA.

Morten B StrømNatural Products and Medicinal Chemistry Research Group, Department of Pharmacy, UiT The Arctic University of Norway, N-9037, Tromsø, Norway.

Adyary FallareroDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland.

Montana State University · USUiT The Arctic University of Norway · NOUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial biofilms account for up to 80% of all infections and complicate successful therapies due to their intrinsic tolerance to antibiotics. Biofilms also cause serious problems in the industrial sectors, for instance due to the deterioration of metals or microbial contamination of products. Efforts are put in finding novel strategies in both avoiding and fighting biofilms. Biofilm control is achieved by killing and/or removing biofilm or preventing transition to the biofilm lifestyle. Previous research reported on the anti-biofilm potency of α,α-disubstituted β-amino amides

Identifiers

PMID37662850

DOI10.1016/j.bioflm.2023.100151

PMCPMC10474319

OpenAlexW4386170801

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.